From the group at Syneos Health Consulting that authors the Dealmakers’ Intentions Survey comes the latest BioPharma BD newsletter highlighting financial deal spend in the biopharma industry. In the report you will find an overview of H2 2019 BD activity, including the most valuable M&A and partnership deals as well as IPOs, FDA approvals and more.
